Market open
Elicio Therapeutics Inc./$ELTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
Ticker
$ELTX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
32
ISIN
US28657F1030
Website
ELTX Metrics
BasicAdvanced
$89M
-
-$4.25
-
-
Price and volume
Market cap
$89M
52-week high
$8.84
52-week low
$4.60
Average daily volume
43K
Financial strength
Current ratio
1.796
Quick ratio
1.529
Long term debt to equity
-222.233
Total debt to equity
-230.198
Interest coverage (TTM)
-98.87%
Management effectiveness
Return on assets (TTM)
-101.64%
Return on equity (TTM)
-170,157.38%
Valuation
Price to book
-5.43
Price to tangible book (TTM)
-5.43
Price to free cash flow (TTM)
-1.829
Growth
Earnings per share change (TTM)
-38.90%
3-year earnings per share growth (CAGR)
35.02%
ELTX News
AllArticlesVideos
Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires
GlobeNewsWire·3 weeks ago
Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates
GlobeNewsWire·1 month ago
Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Elicio Therapeutics Inc. stock?
Elicio Therapeutics Inc. (ELTX) has a market cap of $89M as of May 09, 2025.
What is the P/E ratio for Elicio Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Elicio Therapeutics Inc. (ELTX) stock is 0 as of May 09, 2025.
Does Elicio Therapeutics Inc. stock pay dividends?
No, Elicio Therapeutics Inc. (ELTX) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next Elicio Therapeutics Inc. dividend payment date?
Elicio Therapeutics Inc. (ELTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Elicio Therapeutics Inc.?
Elicio Therapeutics Inc. (ELTX) does not currently have a Beta indicator.